DOI: 10.36347/sasjm.2023.v09i11.016

Pages: 1210-1216

Individuals with Intellectual Developmental Disorder (IDD) face elevated rates of anxiety, challenging previous assumptions of immunity to mental health issues. Prevalence rates of anxiety disorders in this population can be as high as 84%, surpassing typical populations. Specific syndromes, genetic factors, and challenges in diagnosis are highlighted, emphasizing the need for tailored assessment tools. The SCARED questionnaire is identified as a valid tool. Psychological treatments, especially Cognitive Behavioral Therapy (CBT), show promise, but evidence is limited. Pharmacological treatments, including SSRIs, are used, but studies are scarce. This overview contributes to a more comprehensive understanding of anxiety in individuals with IDD and underscores the importance of targeted interventions.